Table 2.
Outline of results
|
Timing QoL measure |
Pre operative | 2 d | 1-2 wk | 4-8 wk | 12 wk | 6 mo | 1 yr | 1.5-2 yr | 3-6.7 yr | |
| Author | QoL measure | |||||||||
| Janson et al[28] | EORTC-C30 | NS | - | LAP (2/15) | LAP (1/15) | NS | - | - | - | - |
| EQ-5D | OPEN (1/5) | - | NS | NS | NS | - | - | - | - | |
| King et al[33,34] | EORTC-C30 | NS | - | NS | NS | NS | NS | NS | - | - |
| EORTC-C38 | NS | - | NS | NS | NS | NS | NS | - | - | |
| Guillou et al[4], | EORTC-C30 | NS1 | - | NS1 | - | NS1 | NS1 | NS1 | NS1 | |
| Jayne et al[35] | EORTC-C38 | NS1 | - | NS1 | - | NS1 | NS1 | NS1 | NS1 | |
| Braga et al[29] | SF-36 | - | - | - | - | - | - | LAP (2/3) | LAP (1/3) | NS |
| Weeks et al[30] | QLI | NS | - | NS | NS | - | - | - | - | - |
| SDS | NS | NS | NS | NS | - | - | - | - | - | |
| Global QOL | NS | - | LAP | NS | - | - | - | - | - | |
| Schwenk et al[31] | EORTC-C30 | NS | - | LAP (9/15) | LAP (3/15) | NS | - | - | - | - |
| Klarenbeek et al[1] | SF-36 | NS | - | - | LAP (4/8) | - | - | - | - | - |
| Maartense et al[32], | SF-36 | NS | - | NS | NS | NS | - | - | - | NS |
| Eshuis et al[36] | GIQLI | NS | - | NS | NS | NS | - | - | - | NS |
| Maartense et al[2], | SF-36 | NS | - | NS | NS | NS | - | NS | - | - |
| Polle et al[37] | GIQLI | NS | - | NS | NS | NS | - | NS | - | - |
LAP: Significantly in favor of laparoscopic group; OPEN: Significantly in favor of open group; (1/5): In 1 out of 5 subscales; NS: No significant difference between laparoscopic and open surgery (P > 0.05);
1
P > 0.01; -: No data available; EORTC: European Organization for Research and Treatment of Cancer; SDS: Symptom Distress Scale; QLI: Quality of Life Index; QoL: Quality of life; GIQLI: Gastro Intestinal Quality of Life Index; SF-36: Short Form-36.